Schering-Plough is a company committed to improving the health and well-being of people throughout the world. They view their work as the science of life, improving, extending and saving it. Schering-Plough faces enormous challenges, considering that only one in 10,000 molecules screened by scientists becomes an innovative new medicine. The rewards and benefits are equally as enormous-for the patients and customers who are waiting.

Through their investments in biopharmaceutical research, development and manufacturing, Schering-Plough creates therapies that help to save and improve lives globally. They are also closely linked to their global animal health business which is an industry leader, serving veterinarians, farmers and pet owners with important products and services

Dr. Enrico P. Veltri is the group Vice President of Schering-Plough. Specializing in cardiology, he has assisted in Schering-Plough in emerging as a global leader in treated cardiovascular disease. Cardiovascular disease is the leading cause of death in the United States and many other countries. High LDL cholesterol is a major risk factor for which Schering-Plough has developed two cholesterol lowering medications. Dr. Veltri is also overseeing the building of a portfolio consisting of other therapies to treat and prevent such killers and heart attack and stroke.

Dr. Enrico P. Veltri can be found in the Madison Who’s Who directory and looks forward to networking with you.

www.schering-plough.com